Hypersensitivity of the climbing behaviour response to apomorphine induced by a short depression of dopaminergic neurone activity.
D015107:4-Butyrolactone / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001418:Baclofen / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D006885:Hydroxybutyrates / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009474:Neurons / Q000502:physiology*; D012978:Sodium Oxybate
D006885:Hydroxybutyrates; D012978:Sodium Oxybate; D003513:Cycloheximide; D001418:Baclofen; D001058:Apomorphine; D015107:4-Butyrolactone; D004298:Dopamine